BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24294744)

  • 1. [Probiotic monotherapy of bacterial vaginosis: a open, randomized trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():36-42. PubMed ID: 24294744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of Lactobacillus casei var rhamnosus (Gynophilus) in restoring the vaginal flora by female patients with bacterial vaginosis--randomized, open clinical trial].
    Kovachev S; Dobrevski-Vacheva R
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():48-53. PubMed ID: 24294746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of combined 5-nitroimidazole and probiotic therapy of bacterial vaginosis: randomized open trial].
    Kovachev S; Vatcheva-Dobrevski R
    Akush Ginekol (Sofiia); 2013; 52(3):19-26. PubMed ID: 24283058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis.
    Recine N; Palma E; Domenici L; Giorgini M; Imperiale L; Sassu C; Musella A; Marchetti C; Muzii L; Benedetti Panici P
    Arch Gynecol Obstet; 2016 Jan; 293(1):101-107. PubMed ID: 26142892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis.
    Anukam KC; Osazuwa E; Osemene GI; Ehigiagbe F; Bruce AW; Reid G
    Microbes Infect; 2006 Oct; 8(12-13):2772-6. PubMed ID: 17045832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial.
    Anukam K; Osazuwa E; Ahonkhai I; Ngwu M; Osemene G; Bruce AW; Reid G
    Microbes Infect; 2006 May; 8(6):1450-4. PubMed ID: 16697231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term vaginal administration of Lactobacillus rhamnosus as a complementary approach to management of bacterial vaginosis.
    Marcone V; Rocca G; Lichtner M; Calzolari E
    Int J Gynaecol Obstet; 2010 Sep; 110(3):223-6. PubMed ID: 20573348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.
    Heczko PB; Tomusiak A; Adamski P; Jakimiuk AJ; Stefański G; Mikołajczyk-Cichońska A; Suda-Szczurek M; Strus M
    BMC Womens Health; 2015 Dec; 15():115. PubMed ID: 26635090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.
    Palma E; Recine N; Domenici L; Giorgini M; Pierangeli A; Panici PB
    BMC Infect Dis; 2018 Jan; 18(1):13. PubMed ID: 29304768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study.
    Vicariotto F; Mogna L; Del Piano M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S106-12. PubMed ID: 25291116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis.
    Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
    BMC Infect Dis; 2019 Sep; 19(1):824. PubMed ID: 31533663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis.
    Nyirjesy P; McIntosh MJ; Gattermeir DJ; Schumacher RJ; Steinmetz JI; Joffrion JL
    Am J Obstet Gynecol; 2006 May; 194(5):1277-82. PubMed ID: 16647910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.
    Hummelen R; Changalucha J; Butamanya NL; Cook A; Habbema JD; Reid G
    Int J Gynaecol Obstet; 2010 Dec; 111(3):245-8. PubMed ID: 20801446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S; Brandsborg E; Hammarström L; Marcotte H; Larsson PG
    BMC Infect Dis; 2015 Jul; 15():255. PubMed ID: 26137971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based mixture containing Lactobacillus strains and lactoferrin to prevent recurrent bacterial vaginosis: a double blind, placebo controlled, randomised clinical trial.
    Russo R; Karadja E; De Seta F
    Benef Microbes; 2019 Feb; 10(1):19-26. PubMed ID: 30525953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Oral Probiotic
    Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population.
    Vaccalluzzo A; Pino A; Grimaldi RL; Caggia C; Cianci S; Randazzo CL
    J Appl Microbiol; 2024 May; 135(5):. PubMed ID: 38755019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of probiotics on the recurrence of bacterial vaginosis: a review.
    Homayouni A; Bastani P; Ziyadi S; Mohammad-Alizadeh-Charandabi S; Ghalibaf M; Mortazavian AM; Mehrabany EV
    J Low Genit Tract Dis; 2014 Jan; 18(1):79-86. PubMed ID: 24299970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.